Engstrand, Lars
Graham, David Y.
Article History
First Online: 10 February 2020
Compliance with Ethical Standards
:
: Dr. Graham is a consultant for RedHill Biopharma and Phathom Pharmaceuticals regarding novel <i>H. pylori</i> therapies and has received research support for culture of <i>Helicobacter pylori</i> and is the PI of an international study of the use of antimycobacterial therapy for Crohn’s disease. Dr. Engstrand has no relevant conflicts.